Efficacy of smoking cessation therapy alone or integrated with prolonged exposure therapy for smokers with PTSD: Study protocol for a randomized controlled trial
- PMID: 27568069
- PMCID: PMC5695545
- DOI: 10.1016/j.cct.2016.08.012
Efficacy of smoking cessation therapy alone or integrated with prolonged exposure therapy for smokers with PTSD: Study protocol for a randomized controlled trial
Abstract
Posttraumatic stress disorder (PTSD) is related to an increased risk of smoking cessation failure. In fact, the quit rate in smokers with PTSD (23.2%) is one of the lowest of all mental disorders. Features of PTSD that contribute to smokers' progression to nicotine dependence and cessation relapse include negative affect, fear, increased arousal, irritability, anger, distress intolerance, and anxiety sensitivity. Anxiety sensitivity is higher in people with PTSD than in any other anxiety disorder except for panic disorder. High anxiety sensitivity is uniquely associated with greater odds of lapse and relapse during quit attempts. Distress intolerance, a perceived or behavioral tendency to not tolerate distress, is related to both the maintenance of PTSD and problems in quitting smoking. Prolonged exposure (PE) and interoceptive exposure (IE) reduce PTSD symptoms, distress intolerance, and anxiety sensitivity. Thus, they emerge as promising candidates to augment standard smoking cessation interventions for individuals with PTSD. The present study tests a 12-session specialized treatment for smokers with PTSD. This Integrated PTSD and Smoking Treatment (IPST) combines cognitive-behavioral therapy and nicotine replacement treatment for smoking cessation (standard care; SC) with PE to target PTSD symptoms and IE to reduce anxiety sensitivity and distress intolerance. Adult smokers (N=80) with PTSD will be randomly assigned to either: (1) IPST or (2) SC. Primary outcomes are assessed at weeks 0, 6, 8, 10, 14, 16, 22, and 30.
Keywords: Behavioral intervention; Clinical trial; PTSD; Smoking cessation.
Copyright © 2016. Published by Elsevier Inc.
Conflict of interest statement
None of the authors have conflicts to report within the last 2 years.
Figures
References
-
- Abrams K, Zvolensky MJ, Dorman L, Gonzalez A, Mayer M. Development and validation of the smoking abstinence expectancies questionnaire. Nicotine Tob. Res. 2011 ntr184, http://dx.doi.org/10.1093/ntr/ntr184. - DOI - PubMed
-
- Agrawal S, Sobell MB, Sobell L. The timeline follow-back: a scientifically and clinically useful tool for assessing substance use, Calendar and Time Diary. SAGE Publications Inc.; Thousand Oaks, CA: 2008. pp. 57–68.
-
- Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol. Rev. 2004;111:33–51. http://dx.doi.org/10.1037/0033-295X.111.1.33. - DOI - PubMed
-
- Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry. 1961;4:561–571. - PubMed
-
- Beckham JC, Kirby AC, Feldman ME, Hertzberg MA, Moore SD, Crawford AL, Davidson JRT, Fairbank JA. Prevalence and correlates of heavy smoking in Vietnam veterans with chronic posttraumatic stress disorder. Addict. Behav. 1997;22:637–647. http://dx.doi.org/10.1016/S0306-4603(96)00071-8. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
